LAVA Therapeutics NV Total Assets

LAVA Therapeutics NV posts a total assets of $52M as of September 2025. That compares with $83M in the prior-year period — down 37.7% year over year. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

In the prior comparable period, LAVA Therapeutics NV's total assets was $83M. The latest reading is $52M — a 37.7% year-over-year decrease (period ending September 2025). Use the history and growth charts on this page for a longer lookback.

Total Assets is one piece of LAVA Therapeutics NV's financial statement story. At $52M, it should be interpreted next to related metrics — for example revenue with costs, assets with liabilities, or income with margins. Stockcircle links those related pages so you can move from this number to the surrounding context quickly.

Context for LVTX's total assets usually means three checks: (1) trend versus prior periods, (2) level versus peers, and (3) consistency with growth and profitability. This page covers the first two; LAVA Therapeutics NV's other metric pages and overview cover the third.

Judging LAVA Therapeutics NV against Healthcare peers is usually better than using a market-wide rule of thumb. Business models inside Healthcare are more comparable, which makes gaps in total assets easier to interpret. Start with $52M here, then scan peer and history charts to see if the gap is persistent.